Drug
rhBNP
rhBNP is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 43 (75.0%)
Trials by Status
unknown375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_4
Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
NCT04033861
unknownphase_4
Early rhBNP on Myocardial Work in Patients With STEMI
NCT04157868
completedphase_4
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909
unknownphase_2
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
NCT01625403
Clinical Trials (4)
Showing 4 of 4 trials
NCT04033861Phase 4
Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI
NCT04157868Phase 4
Early rhBNP on Myocardial Work in Patients With STEMI
NCT02742909Phase 4
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT01625403Phase 2
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4